Robust Calibration Design in the Pharmaceutical Quantitative Measurements with Near-Infrared (NIR) Spectroscopy: Avoiding the Chemometric Pitfalls

被引:45
作者
Xiang, Dong [1 ]
Berry, Joseph [1 ]
Buntz, Susan [1 ]
Gargiulo, Paul [1 ]
Cheney, James [1 ]
Joshi, Yatindra [1 ]
Wabuyele, Busolo [1 ]
Wu, Huiquan [2 ]
Hamed, Mazen [2 ]
Hussain, Ajaz S. [3 ]
Khan, Mansoor A. [2 ]
机构
[1] Novartis Pharmaceut, Pharmaceut & Analyt Dev, E Hanover, NJ 07936 USA
[2] FDA CDER OPS OTR, Div Prod Qual Res, Silver Spring, MD 20993 USA
[3] Philip Morris Prod SA, Biol Syst R&D, Philip Morris Int Res & Dev, CH-2000 Neuchatel, Switzerland
关键词
near-infrared (NIR); pharmaceutical tablets; content uniformity; multivariate calibration design; partial least-squares regression (PLS); CONTENT UNIFORMITY; DOSAGE FORMS; MODELS; SPECTRA; ASSAY; PRODUCTS; TABLETS;
D O I
10.1002/jps.21482
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Quantification analysis with near-infrared (NIR) spectroscopy typically requires utilizing chemometric techniques, such as partial least squares (PLS) method, to achieve the desired selectivity. This article points out a major limitation of these statistical-based calibration methods. The limitation is that the techniques suffer from the potential for chance correlation. In this article, the impact of chance correlation oil the robustness of PLS model was illustrated via a pharmaceutical application with NIR to the content uniformity determination of tablets. The procedure involves evaluating the PLS models generated with two sets of calibration tablets incorporated with distinct degree of concentration correlation between the active pharmaceutical ingredient (API) and excipients. The selectivity and robustness of the two models were examined by using a series of data sets associated with placebo tablets and tablets incorporated with variations from excipient content, hardness and particle size. The result clearly revealed that the strong correlation observed in the PLS model created by the correlated design was not solely based on the API information, and there was an intrinsic difference in the variances described by the two calibration models. Diagnostic tools that enable the characterization of the chemical selectivity of the calibration model were also proposed for pharmaceutical quantitative analysis. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:1155-1166, 2009
引用
收藏
页码:1155 / 1166
页数:12
相关论文
共 20 条
[1]
[Anonymous], ANN BOOK ASTM STAND
[2]
Pure component selectivity analysis of multivariate calibration models from near-infrared spectra [J].
Arnold, MA ;
Small, GW ;
Xiang, D ;
Qui, J ;
Murhammer, DW .
ANALYTICAL CHEMISTRY, 2004, 76 (09) :2583-2590
[3]
Phantom glucose calibration models from simulated noninvasive human near-infrared spectra [J].
Arnold, MA ;
Burmeister, JJ ;
Small, GW .
ANALYTICAL CHEMISTRY, 1998, 70 (09) :1773-1781
[4]
Application of transmission near-infrared spectroscopy to uniformity of content testing of intact steroid tablets [J].
Broad, NW ;
Jee, RD ;
Moffat, AC ;
Smith, MR .
ANALYST, 2001, 126 (12) :2207-2211
[5]
Burmeister JJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P50, DOI 10.1562/0031-8655(1998)067<0050:PFNBGS>2.3.CO
[6]
2
[7]
Near infrared transmittance analysis for the assay of solid pharmaceutical dosage forms [J].
Corti, P ;
Ceramelli, G ;
Dreassi, E ;
Mattii, S .
ANALYST, 1999, 124 (05) :755-758
[8]
Mixture design design generation, PLS analysis, and model usage [J].
Eriksson, L ;
Johansson, E ;
Wikström, C .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1998, 43 (1-2) :1-24
[9]
Robust methods for partial least squares regression [J].
Hubert, M ;
Vanden Branden, K .
JOURNAL OF CHEMOMETRICS, 2003, 17 (10) :537-549
[10]
DETERMINATION OF FILM-COATED TABLET PARAMETERS BY NEAR-INFRARED SPECTROSCOPY [J].
KIRSCH, JD ;
DRENNEN, JK .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (10) :1273-1281